<?xml version="1.0" encoding="UTF-8"?>
<ref id="B32">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Corbett</surname>
    <given-names>K. S.</given-names>
   </name>
   <name>
    <surname>Moin</surname>
    <given-names>S. M.</given-names>
   </name>
   <name>
    <surname>Yassine</surname>
    <given-names>H. M.</given-names>
   </name>
   <name>
    <surname>Cagigi</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Kanekiyo</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Boyoglu-Barnum</surname>
    <given-names>S.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2019</year>). 
  <article-title>Design of nanoparticulate group 2 influenza virus hemagglutinin stem antigens that activate unmutated ancestor B cell receptors of broadly neutralizing antibody lineages</article-title>. 
  <source>MBio</source>
  <volume>10</volume>:
  <fpage>e02810</fpage>â€“
  <lpage>18</lpage>. 
  <pub-id pub-id-type="doi">10.1128/mBio.02810-18</pub-id>
  <?supplied-pmid 30808695?>
  <pub-id pub-id-type="pmid">30808695</pub-id>
 </mixed-citation>
</ref>
